Next report date
Report period
Q2 2024
EPS estimate
0.47MXN
Revenue estimate
4.63 BMXN
1.10MXN
1.03 BMXN
16.47 BMXN
709.29 M
About GENOMMA LAB INTERNACIONAL SAB
Sector
CEO
Marco Sparvieri
Headquarters
Mexico City
Website
Employees (FY)
1.59 K
Founded
1996
ISIN
MX01LA010006
FIGI
BBG00JX0PJG5
Genomma Lab Internacional SAB de CV engages in the development, manufacturing and marketing of pharmaceutical, beauty and personal care products. The company was founded by Rodrigo Alonso Herrera Aspra on October 30, 1996 and is headquartered in Mexico City, Mexico.
Expecting a 50% return This is one of the favorites for this year for analysts. The overall recommendation is to buy and in this technical analysis we can see that the price is approaching a medium level support horizontal line that coincides with the 61% fib. My recommendation is to wait till the price hits the lower poi
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of LAB/B is 16.35 MXN — it has increased by 3.74% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V stocks are traded under the ticker LAB/B.
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V is going to release the next earnings report on Jul 24, 2024. Keep track of upcoming events with our Earnings Calendar.
LAB/B stock is 3.73% volatile and has beta coefficient of 0.67. Check out the list of the most volatile stocks — is GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V there?
LAB/B earnings for the last quarter are −0.11 MXN per share, whereas the estimation was 0.20 MXN resulting in a −155.30% surprise. The estimated earnings for the next quarter are 0.36 MXN per share. See more details about GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V earnings.
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V revenue for the last quarter amounts to 3.53 B MXN despite the estimated figure of 3.79 B MXN. In the next quarter revenue is expected to reach 3.91 B MXN.
Yes, you can track GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V financials in yearly and quarterly reports right on TradingView.
LAB/B stock has risen by 12.14% compared to the previous week, the month change is a 5.28% rise, over the last year GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V has showed a 7.92% increase.
LAB/B net income for the last quarter is 372.11 M MXN, while the quarter before that showed −115.50 M MXN of net income which accounts for 422.18% change. Track more GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V financial stats to get the full picture.
Today GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V has the market capitalization of 16.63 B, it has increased by 6.89% over the last week.
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V dividend yield was 4.15% in 2023, and payout ratio reached 54.47%. The year before the numbers were 3.41% and 41.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, LAB/B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 1.59 K employees. See our rating of the largest employees — is GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V stock shows the buy signal. See more of GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V future price: according to them, LAB/B price has a max estimate of 25.00 MXN and a min estimate of 16.00 MXN. Read a more detailed GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V forecast: see what analysts think of GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V EBITDA is 3.60 B MXN, and current EBITDA margin is 21.14%. See more stats in GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V financial statements.